AMD Lasers, Inc., a subsidiary of the CAO Group, Inc., announced the launch of LEAP (Laser Endodontic Ablation Procedure), a laser-assisted root canal disinfection system that will be introduced at the 2026 American Association of Endodontists Annual Meeting beginning April 15, 2026. According to the company, the system is designed to deliver complete bacterial elimination while simplifying clinical workflow.
The LEAP system integrates the Picasso Pro diode laser, a proprietary disinfection solution, and engineered fiber tips into a single protocol. According to the company, all elements of the system and the overall protocol have received FDA approval. Independent laboratory research cited by the company demonstrates greater than 99.99% bacterial reduction against Enterococcus faecalis.
Canal disinfection remains a central component of root canal treatment and has been a focus of research for more than 200 years. Conventional approaches typically rely on chemical irrigation, most commonly sodium hypochlorite, which may involve risks such as tissue toxicity, procedural complexity, and extended contact times.
The company stated that its research and development efforts led to a method that converts diode laser energy into controlled thermal ablation within the root canal system. According to the company, this process eliminates residual bacteria while preserving surrounding structures, including cementum and the periodontal ligament.
The LEAP fiber tip, starting at 200 µm in diameter, enables access to the apical third of the canal with minimal enlargement, according to the company. The system combines the diode laser, treatment protocol software, irrigation solution, and disposable fiber tips to support controlled thermal disinfection and deep canal penetration.
Independent laboratory testing cited by the company showed greater than 99.99% reduction of E. faecalis. Early clinical evaluation referenced by the company reported that 80% of patients experienced no pain within 24 hours and 100% reported no pain after seven days.
According to the company, the LEAP protocol reduces the number of steps in endodontic procedures, including minimizing file sequences, reducing irrigation steps, and shortening solution exposure time. The protocol also eliminates the need for sodium hypochlorite. These changes may reduce procedure time by up to 50% and decrease the likelihood of multi-visit treatments, according to the company.
The Picasso Pro diode laser platform used in the system supports multiple dental procedures, including soft tissue management, laser assisted pain alleviation, photobiomodulation therapy, and endodontic applications. According to the company, the platform includes a dedicated LEAP protocol mode, an iPad-based interface, and a compact design for operatory integration.
“LEAP represents the first fully integrated diode laser protocol specifically designed for root canal disinfection and is a part of our continuous innovation in dentistry,” said Densen Cao, PhD, CEO of CAO Group, AMD’s parent company. “By achieving greater than 99.99% bacterial reduction while eliminating sodium hypochlorite and significantly reducing procedure time, LEAP provides clinicians with a repeatable, reliable, and affordable canal disinfection technology. We believe this innovation represents a revolutionary advancement in dental root canal treatment.”
According to the company, the system is intended to improve operational efficiency by reducing treatment time and simplifying workflows. More information is available at www.amdlasers.com.
